Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107686457B reveals a ferrous salt-catalyzed synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN112159380B discloses a safe, low-temperature route for Barosavir intermediates, eliminating toxic reagents and enabling cost reduction in API manufacturing.
New patent CN116715573B reveals high-yield synthesis route for 2 2-dimethylbutyryl chloride offering significant purity improvements and supply chain stability for pharmaceutical manufacturers.
Novel iron-catalyzed method for stereoselective synthesis of heterocyclic intermediates. Reduces heavy metal reliance and enables efficient deuterium labeling for drug development.
Novel copper catalyzed route offers high yield quinoline amides. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103429567A details a mild Rh-catalyzed process for chiral amino acids with >98% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN102850379B details high-yield 7-MAC synthesis. Offers supply chain reliability and cost reduction for cephalosporin intermediate manufacturing.
Novel supramolecular method achieves >99.9% purity resveratrol by removing 3,4'-dihydroxystilbene. Green, scalable process for pharmaceutical intermediates.
Novel chromium-free oxidation route for high-purity diacerein production ensuring cost efficiency and supply chain stability.
Patent CN113105329B details a palladium-free synthesis route for estrogen antagonist intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112979602B reveals a safer, scalable route for Baloxavir Marboxil intermediates, eliminating toxic selenium and cryogenic conditions for reliable supply.
Patent CN105820166A enables green photocatalytic synthesis of dihydrocarboline. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111116552B details a novel one-step synthesis of quinazolinones using vinyl heterocycles, offering high purity and scalable routes for pharmaceutical intermediate suppliers.
Advanced solid-phase peptide synthesis method reduces costs and improves supply chain reliability for high-purity Exenatide manufacturing globally.
Patent CN114685300A reveals a novel synthesis for o-chlorophenylglycine, eliminating red oil by-products and decolorization steps for superior cost efficiency and supply reliability.
Novel preparation method for Ozanimod intermediate offering high purity and scalable manufacturing solutions for pharmaceutical supply chains.
Novel three-step synthesis avoids palladium catalysts reducing cost and environmental impact for reliable API intermediate supply chains globally
Novel Entecavir preparation method enhances yield and purity. Reduces manufacturing complexity for reliable pharmaceutical intermediate supply chain stability.
Patent CN116041222B reveals safer midazolam synthesis. High purity, reduced steps, scalable for pharmaceutical intermediates supply chain efficiency.
Patent CN108929304B reveals a high-selectivity decarboxylation route for trans-dioxane intermediates, offering superior purity and scalable manufacturing for pharma applications.